The U.S. Food and Drug Administration (FDA) approved Adasuve (loxapine) for the acute treatment of agitation caused by schizophrenia or bipolar 1 disorder.
Adasuve is the first non-injectable form of therapy for symptoms of agitation.
Two phase 3 clinical trials involving 1,600 patients were carried out with either Adasuve or... Read more
Bill MacPhee, the founder and CEO of SZ magazine, wrote in one of his editor's letters that the goal is not to set the bar high. The goal is to set it. Period.
We have not only NOT set the bar for mental health treatment. We have perpetuated the blatant neglect of our citizens' mental health that leads to the killing of... Read more
In my estimation: Establishing a routine is the foundation of a successful recovery.
I wrote about this elsewhere and talked about the trend of reality TV where the drama, the bickering, the endless public scrutiny can't be healthy. It can't be healthy to live your life as if you're in your own reality TV show.
I propose... Read more
I'm going to dedicate this SharePost to family members whose loved ones have schizophrenia or another mental health condition. For ease of writing, I refer to this person as "he" though I realize the person could be a "she."
Not only was I diagnosed with schizophrenia when I was 22, I'm also the family member of a loved one with a... Read more
US researchers determined individuals with schizophrenia have elevated levels of high-sensitivity C-reactive protein (CRP) compared with people who do not have this illness.
The study tracked 295 patients with schizophrenia, 192 with bipolar, and 228 controls without a psychiatric condition. The study accounted for age, gender, race,... Read more